Versant Ventures IV LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-14 5:06 pm Sale | 2024-03-21 | 13D | ADVERUM BIOTECHNOLOGIES INC CO ADVM | Versant Ventures IV LLC | 500,387 2.400% | -2 (-0.00%) | Filing |